Skip to content

Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury

Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02731027
Acronym
SCIMARK
Enrollment
42
Registered
2016-04-07
Start date
2015-10-31
Completion date
2020-09-30
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

The purpose of the study is to profile biochemical responses and measure functional recovery in parallel, throughout the 1st year after spinal cord injury (SCI), within the same participants. These responses and recovery will be evaluated in samples from people who have had a spinal cord injury due to trauma (e.g. car accident or a fall) within the first year after SCI. Specifically, the investigators will test the hypothesis that a subset of inflammatory biomarkers correlate inversely with functional recovery. The investigators will use these data to build a predictive model of functional recovery after SCI that incorporates biomarkers that can be easily quantified in the clinic. Total anticipated enrollment will be 100 participants with SCI across three different sites (Northwell Health System (NY), The Kessler Institute for Rehabilitation (NJ), University of Louisville (KY) and may enroll up to 30 participants without SCI.

Detailed description

At all study visits, a member of the study team (investigator) will collect basic demographic and health information from the participant or the participant's medical record. Study participants will have blood drawn at each study visit (approximately 2 tablespoons). The participant will be asked to partake in 4 study visits over the course of 1 year. The first visit will be within the first 0-14 days of SCI. The 2nd, 3rd, and 4th visits will be 3, 6, and 12 months after their spinal cord injury. At study visits 2, 3 and 4, a study investigator will also perform some clinical evaluations for research purposes to test how the participant is recovering the ability to perform activities of daily living and move after spinal cord injury.

Interventions

None listed

Sponsors

United States Department of Defense
CollaboratorFED
New York State Department of Health
CollaboratorOTHER_GOV
University of Louisville
CollaboratorOTHER
Kessler Foundation
CollaboratorOTHER
Thomas Jefferson University
CollaboratorOTHER
University of British Columbia
CollaboratorOTHER
Ohio State University
CollaboratorOTHER
Northwell Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

SCI Subject Inclusion Criteria: To be eligible for prospective enrollment, participants are required to meet the following inclusion criteria: * ≥18 years old with traumatic SCI * Injury within 0-3 days post injury prior to enrollment * All American Spinal Injury Association (ASIA) grade classification A-D. * Neurological injury level C4-T10

Exclusion criteria

To be eligible for prospective enrollment, SCI subjects are required to not meet the following

Design outcomes

Primary

MeasureTime frameDescription
Circulating inflammatory response from the peripheral blood for each SCI participant1 yearSample 1 will take place at the earliest possible time within 0-3 days post SCI. All blood products will be collected with strict adherence to universal precautions, and whenever possible, will occur concurrently with clinical blood draws. Blood samples collected from patients with documented concurrent infections such as UTI, as indicated by fever, hematuria or increased spasticity with the presence of pyuria (\>25 wbc/high power field), which will raise inflammatory biomarker levels independent of SCI, will be analyzed as a subgroup.
ASIA Impairment Scale (AIS) Grade for each SCI participant1 yearThe AIS grade will be the primary functional outcome measure. Data will be collected once acutely (0-3 days), and at 3, 6, and 12 months after SCI.

Secondary

MeasureTime frameDescription
Spinal Cord Independence Measure (SCIM) for each SCI participant1 yearThe SCIM score will be a secondary measure to assess sensitivity to changes in ability to perform activities of daily living and facilitate a multiscale correlative analysis with biochemical variables measured. Data will be collected once at 3, 6, 12 months after SCI.
Neuromuscular Recovery Scale (NRS) for each SCI participant1 yearTo assess ability to perform tasks related to mobility, standing and walking for each SCI participant. Data will be collected once at 3,6,12 months after SCI.

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026